DeepInfer: High-performance, large-scale inference framework for DeepSeek models
Read more →Stars 15.7k
Latest in AI and developer tools
The top stories in the fields you follow, at 06:00 your time.
The Series A round, which included participation from North Island Ventures and existing investors, brings New York-based Mural's total funding to $28 million.
OpenAI is acquiring startup Orchestra Bio and plans to merge it with its life sciences AI platform Rosalind. The goal is to build AI agents that help pharma teams coordinate drug development, from tracking trials to spotting problems. Developing a new drug in the US takes ten to 15 years on average. OpenAI already works with Novo Nordisk and Moderna on AI-driven pharma research.
Read more →Enterprises are deploying AI agents on top of incomplete and siloed workforce data that sit scattered across HR and finance systems and a decade of point solutions, each with its own definitions and blind spots.
Read more →Kinsus Interconnect approves NT$23.5B capex for AI chip ABF substrates, expanding its K6 plant as AI revenue share climbs toward 15% by 2026.
Read more →Researchers at Georgetown's Center for Security and Emerging Technology (CSET) categorised the risks of AI-generated code into three groups, which shows this is a multipart problem: The first category shows up in practice,
Read more →Rises show once there are 4 weeks of history (from mid-November).
